Focusing specifically on the 16 EGFR‐mutated NSCLC patients, the Cox regression indicated a hazard ratio of 1.525 (p = 0.450) for TKI use, a finding that was not statistically significant. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.